AzTrials
AzTrials

Post Stroke AphasiaNCT03433495

Adaptation of Melodic Intonation Therapy to Spanish

A study testing Melodic Intonation Therapy in people with Post Stroke Aphasia, run by Instituto de Investigación Hospital Universitario La Paz.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was conducted in three phases: The first phase involved creation of a Spanish adaptation of the Melodic Intonation therapy; the second phase consisted of a pilot non-randomized intervention study to analyse its feasibility for use with 4 Spanish patients with poststroke nonfluent aphasia; the third phase… Read more about this study

Who is it for?
Any age
Conditions the study is for
Post Stroke Aphasia
What is being tested?
Melodic Intonation Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Feb 2010to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients diagnosed with nonfluent aphasia due to unilateral stroke in the left hemisphere without neuroimaging evidence of lesions in the right hemisphere who fulfilled the following criteria:
  • The time elapsed since the stroke exceeded 6 months.
  • Patient had received a standard program of conventional speech therapy after stroke.
  • Persistent nonfluent aphasia with the following characteristics:
  • Severely restricted language, which might be limited to meaningless stereotypy; unlike that observed in verbal tasks, the patient might produce some real and relevant words when singing familiar songs.
  • Poor repetition, even for single words.
Show all 11Show fewer
  • Moderately preserved language comprehension.
  • The nonstereotyped language was produced with a slurring of speech.
  • The total score for the repetition did not exceed the 70th percentile in the Boston Diagnostic Aphasia Examination. The score was obtained from the average score in three areas: repetition of words and repetition of phrases; listening comprehension exceeding the 15th percentile of Boston Diagnostic Aphasia Examination; and from the average score obtained in three areas: word comprehension, commands and complex ideational material.
  • The patient was motivated, emotionally stable and had good attention.
  • Signed informed consent was provided.

Who cannot join

  • patients with a history of a previous stroke other than the index event or with any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that precluded appropriate follow-up in the study
  • patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
  • use of psychotropic drugs that interfere with patient evaluation.

About this study

Official title: Adaptation of Melodic Intonation Therapy to Spanish: a Feasibility and Validation Pilot Clinical Trial

This study was conducted in three phases:

The first phase involved creation of a Spanish adaptation of the Melodic Intonation therapy; the second phase consisted of a pilot non-randomized intervention study to analyse its feasibility for use with 4 Spanish patients with poststroke nonfluent aphasia; the third phase consisted of a pilot randomised, crossover, intervention pilot trial in a different set of patients with poststroke nonfluent aphasia (N=20)

Being tested
Melodic Intonation Therapy
Keywords
stroke, aphasia, melodic intonation therapy
Medical subject headings
Stroke, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Melodic Intonation TherapyOther

Study groups in NCT03433495
Study groupRoleWhat they receive
Melodic Intonation TherapyActive comparatorThe duration of therapy was 12 sessions performed over a 6-week period. Each session lasted 30 minutes. They were performed individually by a speech-experienced therapist previously trained in Melodic Intonation Therapy.
Receives: Other: Melodic Intonation Therapy
Waiting listNo interventionNo intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Communicative Activity Log questionnaire

    Measured: 6 weeks after the end of therapy

  2. Boston Diagnostic Aphasia Examination

    Measured: 6 weeks after the end of therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2018
  2. Study startFeb 2010
  3. Primary completionFeb 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03433495
Sponsor's protocol ID
PI-894
Status last verified
Feb 2018
First submitted
8 Feb 2018
Last updated
14 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Melodic Intonation Therapy in people with Post Stroke Aphasia, run by Instituto de Investigación Hospital Universitario La Paz.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Communicative Activity Log questionnaire (time frame: 6 weeks after the end of therapy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in